글로벌 비시노시스 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력 : 글로벌 비시노시스 치료 시장

글로벌 비시노시스 치료 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에 언급된 예측 기간 동안 시장이 4%의 CAGR로 성장할 것으로 분석합니다.

비시노시스는 먼지 입자의 만성 흡입으로 인해 발생하는 폐 질환으로, 기도가 좁아지는 결과를 초래합니다. 여기에는 면 먼지나 아마, 대마 또는 사이잘과 같은 다른 식물성 섬유의 먼지가 포함됩니다. 이 질환은 천식 이나 만성 폐쇄성 폐질환(COPD)과 유사한 더 영구적인 폐 손상을 일으킬 수 있습니다. 월요일 열병, 갈색 폐 질환, 공장 열병 및 면화 노동자 폐라고도 합니다. 이 질환의 일반적인 증상은 기침, 호흡 곤란 및 가슴 답답함입니다.

질병 유병률 증가, 비시노시스 위험을 증가시키는 천식 병력 증가, 가공되지 않은 면화 를 다루는 인구 증가 , 정부 주도의 정책 확대, 치료 옵션의 발전, 건강에 대한 인식 제고는 글로벌 비시노시스 치료 시장을 확대할 요인입니다.

증가하는 R&D 활동과 주요 제약회사들의 새로운 치료법에 대한 집중은 2021~2028년 예측 기간 동안 글로벌 비시노시스 치료 시장에 유익한 기회를 제공할 것입니다.

높은 치료 비용과 폐 섬유증, 산소 의존성, 장애, 운동 내성 감소, 조기 사망 등 비시노시스와 관련된 합병증은 시장 성장을 방해하는 요소이며, 위에서 언급한 예측 기간 동안 글로벌 비시노시스 치료 시장에 더욱 어려움을 겪을 것입니다.

This Byssinosis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global byssinosis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Byssinosis Treatment Market Scope and Market Size

The Byssinosis treatment market is segmented on the basis of treatment, diagnosis, route of administration, symptoms, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the byssinosis treatment market is segmented into corticosteroids, bronchodilators, oxygen therapy, breathing exercise, and others.
• On the basis of diagnosis, the byssinosis treatment market is segmented into pulmonary function tests, X-ray, and CT scan.
• On the basis of route of administration, the byssinosis treatment market is segmented into intramuscular, intravenous, oral and others.
• On the basis of symptoms, the byssinosis treatment market is segmented into fever, muscle and joint pain, shivering, tiredness, dry cough, and others.
• On the basis of end-users, the byssinosis treatment market is segmented into clinic, hospital and others.

The byssinosis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Global Byssinosis Treatment Market Country Level Analysis

Global byssinosis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the global byssinosis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the byssinosis treatment market due to the presence of major key players, continuous technological development, well-developed healthcare sector, increasing prevalence of disease, and increasing awareness towards health in this region. Global byssinosis treatment market in the Asia-Pacific and Europe is expected to grow during the forecast period due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global byssinosis treatment market also provides you with detailed market analysis for patient analysis, prognosis, and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Byssinosis Treatment Market Share Analysis

Global byssinosis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to global byssinosis treatment market.

글로벌 비시노시스 치료 시장 보고서에 포함된 주요 기업으로는 Novartis AG, Sanofi, Pfizer Inc., Sumitomo Corporation, Johnson & Johnson Private Limited, AstraZeneca, Cipla Inc., Abbott, Bayer AG, Merck KGaA, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Amneal Pharmaceuticals LLC., Allergan, Boehringer Ingelheim International GmbH, Sunovion Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Mylan NV, Teva Pharmaceutical Industries Ltd., Enzon Pharmaceuticals, Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 각각 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-65573